FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE
Authors:
- R. ChakrabartiRCR. Chakrabarti
- ElizabethD. HockingEHElizabethD. Hocking
- G.R. FearnleyGFG.R. Fearnley
- 1 August 1965
- journal article
- Published by Elsevier in The Lancet
- Vol. 286 (7406) , 256-259
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- PHENFORMIN, SERUM-LIPIDS, AND DIABETES MELLITUSThe Lancet, 1965
- PHYSIOLOGY AND PHARMACOLOGY OF FIBRINOLYSISBritish Medical Bulletin, 1964
- FIBRINOLYTIC ACTIVITY OF VASCULAR ENDOTHELIUMBritish Medical Bulletin, 1964
- Pharmacological enhancement of fibrinolytic activity of bloodJournal of Clinical Pathology, 1964
- Effect of Corticosteroid Therapy on Fibrinolysis in Patients With Inflamatory and Non-inflammatory ConditionsBMJ, 1964
- INCREASE OF BLOOD FIBRINOLYTIC ACTIVITY BY TESTOSTERONEThe Lancet, 1962
- A CONCEPT OF NATURAL FIBRINOLYSISThe Lancet, 1961
- EFFECT OF THE SULPHONYLUREAS ON FIBRINOLYSISThe Lancet, 1960
- Fibrinolysis and Fibrinolytic Activity in ManPhysiological Reviews, 1959
- AN ACCURATE METHOD OF FIBRIN RECOVERY FOR THE DETERMINATION OF PLASMA-FIBRINOGENThe Lancet, 1951